Neurol. praxi. 2024;25(3):203-208 | DOI: 10.36290/neu.2024.031

Specifics of status epilepticus in children

MUDr. Ondřej Horák1, MUDr. Klára Brožová2, MUDr. Martin Kudr, Ph.D.3
1 Centrum pro epilepsie Brno, člen ERN EpiCARE, Klinika dětské neurologie Fakultní nemocnice Brno a Lékařské fakulty Masarykovy univerzity, Brno
2 Oddělení dětské neurologie Fakultní Thomayerovy nemocnice Praha
3 Centrum pro epilepsie Motol, člen ERN EpiCARE, Klinika dětské neurologie 2. lékařské fakulty Univerzity Karlovy a Fakultní nemocnice v Motole, Praha

In comparison to adults, status epilepticus (SE) in childhood is characterized by a higher incidence, different causes, and a lower mortality. Most cases of SE in children occur without a prior history of epileptic seizures. The etiology of SE in children is distinct, with febrile SE being the most common in this age group. Specific to childhood are SE cases in certain epileptic syndromes, such as Dravet syndrome and Lennox-Gastaut syndrome. The treatment of SE in children employs similar algorithms as in adults, but with certain specifics, such as the use of vitamin B6 and a preference for midazolam or thiopental over propofol in younger patients. The mortality associated with SE in children is lower (0-16%) and directly depends on the type and the etiology of SE.

Keywords: status epilepticus, febrile status epilepticus, refractory status epilepticus, childhood.

Received: March 20, 2024; Revised: May 6, 2024; Accepted: May 6, 2024; Prepublished online: May 6, 2024; Published: June 20, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Horák O, Brožová K, Kudr M. Specifics of status epilepticus in children. Neurol. praxi. 2024;25(3):203-208. doi: 10.36290/neu.2024.031.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Eriksson KJ and Koivikko MJ. Status epilepticus in children: aetiology, treatment and outcome. Dev Med Child Neurol. 1997;39(10):652-8. doi: 10.1111/j.1469-8749.1997.tb07358.x. Go to original source... Go to PubMed...
    2. Husari KS, Labiner K, Huang R, et al. New­‑onset Refractory Status Epilepticus in Children: Etiologies, Treatments, and Outcomes. Pediatr Crit Care Med. 2020;21(1):59-66. doi: 10.1097/pcc.0000000000002108. Go to original source... Go to PubMed...
    3. Jafarpoul S, Hodgeman RM, De Marchi Capeletto C, et al. New­‑Onset Status Epilepticus in Pediatric Patients: Causes, Charakteristics, and Outcomes. Pediatr Neurol. 2018;80:61-69. doi: 10.1016/j.pediatrneurol.2017.11.016. Go to original source... Go to PubMed...
    4. Khan Z, Arya K, Bollu PC. "Epilepsia Partialis Continua" v StatPearls. Treasure Island (FL): StatPearls Publishing. 2023; 1. http://www.ncbi.nlm.nih.gov/books/NBK532275/.
    5. Lambrechtsen F, Buchhalter JR. Aborted and refraktory status epilepticus in children: A comparative analysis. Epilepsia. 2008;49(4):615-25. doi: 10.1111/j.1528-1167.2007.01465.x. Go to original source... Go to PubMed...
    6. Lewis DW, Shinnar S, Hesdorffer DC, et al. Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study. Ann Neurol. 2014;75(2):178-85. doi: 10.1002/ana.24081. Go to original source... Go to PubMed...
    7. Mameniškiené R, Wolf P. Epilepsie partialis continua: a review. Seizure. 2017;44(1):74-80. doi: 10.1016/j.seizure.2016.10.010. Go to original source... Go to PubMed...
    8. Maytal J, Shinnar S, Moshé SL, et al. Low morbidity and mortality of status epilepticus in children. Pediatrics. 1989;83(3):323-31. Go to original source...
    9. Mitchell C, Dickson LCh, Ramsay A, et al. Epidemiology and outcome of status epilepticus in children: a Scottish population cohort study. Dev Med Child Neurol. 2021;63(9):1075-84. Go to original source... Go to PubMed...
    10. Okanishi T, Maegaki Y, Ohno K, et al. Underlying neurologic disorders and recurrence rates of status epilepticus in childhood. Brain Dev. 2008;30(10):624-8. doi: 10.1111/dmcn.14900. Go to original source... Go to PubMed...
    11. Raspall­‑Chaure M, Chin RFM, Neville BG, et al. Outcome of paediatric convulsive status epilepticus: a systematic review. Lancet Neurol. 2006;5(9):769-79. doi: 10.1016/S1474-4422(06)70546-4. Go to original source... Go to PubMed...
    12. Scott RC. Adverse outcomes following convulsive status epilepticus in children: relationship with hippocampal injury. Epilepsia. 2010;51(Suppl. 3):178-81. doi: 10.1111/j.1528-1167.2010.02636.x. Go to original source... Go to PubMed...
    13. Seinfeld S, Shinnar S, Sun S, et al. Emergency management of febrile status epilepticus: results of FEBSTAT study. Epilepsia. 2014;55(3):388-95. doi: 10.1111/epi.12526. Go to original source... Go to PubMed...
    14. Shorvon S. The management of status epilepticus. J Neurol Neurosurg Psychiatry. 2001;70(Suppl. 2):II22-7. doi: 10.1136/jnnp.70.suppl_2.ii22. Go to original source... Go to PubMed...
    15. Specchio N, Wirrell EC, Scheffer IE, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1398-1442. doi: 10.1111/epi.17241. Go to original source... Go to PubMed...
    16. Trinka E, Cock H, Hesdorffer D, et al. A Definition and Classification of Status Epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10): 1515-23. Go to original source... Go to PubMed...
    17. van den Munckhof B, Arzimanoglou A, Perucca E, et al. Corticosteroids versus clobazam in epileptic encephalopathy with ESES: a European multicentre randomised controlled clinical trial (RESCUE ESES*). Trials. 2020;21(1):957. doi: 10.1111/epi.13121. Go to original source... Go to PubMed...
    18. Weiss EF, Masur D, Shinnar S, et al. Cognitive functioning one month and one year following febrile status epilepticus. Epilepsy Behav. 2016;64(Pt A):283-288. doi: 10.1016/j.yebeh.2016.09.013. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.